PURPOSE: To evaluate effects of radiation therapy, chemotherapy, cigarette smoking, and alcohol consumption on the risk of second primary salivary gland cancer (SGC) in the Childhood Cancer Survivor Study (CCSS). METHODS AND MATERIALS: Standardized incidence ratios (SIR) and excess absolute risks (EAR) of SGC in the CCSS were calculated using incidence rates from Surveillance, Epidemiology, and End Results population-based cancer registries. Radiation dose to the salivary glands was estimated based on medical records. Poisson regression was used to assess risks with respect to radiation dose, chemotherapy, smoking, and alcohol consumption. RESULTS: During the time period of the study, 23 cases of SGC were diagnosed among 14,135 childhood cancer survivors. The mean age at diagnosis of the first primary cancer was 8.3 years, and the mean age at SGC diagnosis was 24.8 years. The incidence of SGC was 39-fold higher in the cohort than in the general population (SIR = 39.4; 95% CI = 25.4-57.8). The EAR was 9.8 per 100,000 person-years. Risk increased linearly with radiation dose (excess relative risk = 0.36/Gy; 95% CI = 0.06-2.5) and remained elevated after 20 years. There was no significant trend of increasing risk with increasing dose of chemotherapeutic agents, pack-years of cigarette smoking, or alcohol intake. CONCLUSION: Although the cumulative incidence of SGC was low, childhood cancer survivors treated with radiation experienced significantly increased risk for at least 2 decades after exposure, and risk was positively associated with radiation dose. Results underscore the importance of long-term follow up of childhood cancer survivors for the development of new malignancies. Published by Elsevier Inc.
PURPOSE: To evaluate effects of radiation therapy, chemotherapy, cigarette smoking, and alcohol consumption on the risk of second primary salivary gland cancer (SGC) in the Childhood Cancer Survivor Study (CCSS). METHODS AND MATERIALS: Standardized incidence ratios (SIR) and excess absolute risks (EAR) of SGC in the CCSS were calculated using incidence rates from Surveillance, Epidemiology, and End Results population-based cancer registries. Radiation dose to the salivary glands was estimated based on medical records. Poisson regression was used to assess risks with respect to radiation dose, chemotherapy, smoking, and alcohol consumption. RESULTS: During the time period of the study, 23 cases of SGC were diagnosed among 14,135 childhood cancer survivors. The mean age at diagnosis of the first primary cancer was 8.3 years, and the mean age at SGC diagnosis was 24.8 years. The incidence of SGC was 39-fold higher in the cohort than in the general population (SIR = 39.4; 95% CI = 25.4-57.8). The EAR was 9.8 per 100,000 person-years. Risk increased linearly with radiation dose (excess relative risk = 0.36/Gy; 95% CI = 0.06-2.5) and remained elevated after 20 years. There was no significant trend of increasing risk with increasing dose of chemotherapeutic agents, pack-years of cigarette smoking, or alcohol intake. CONCLUSION: Although the cumulative incidence of SGC was low, childhood cancer survivors treated with radiation experienced significantly increased risk for at least 2 decades after exposure, and risk was positively associated with radiation dose. Results underscore the importance of long-term follow up of childhood cancer survivors for the development of new malignancies. Published by Elsevier Inc.
Authors: Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: C Metayer; C F Lynch; E A Clarke; B Glimelius; H Storm; E Pukkala; T Joensuu; F E van Leeuwen; M B van't Veer; R E Curtis; E J Holowaty; M Andersson; T Wiklund; M Gospodarowicz; L B Travis Journal: J Clin Oncol Date: 2000-06 Impact factor: 44.544
Authors: M A Tucker; A T Meadows; J D Boice; M Stovall; O Oberlin; B J Stone; J Birch; P A Voûte; R N Hoover; J F Fraumeni Journal: J Natl Cancer Inst Date: 1987-03 Impact factor: 13.506
Authors: S Bhatia; N K Ramsay; M Steinbuch; K E Dusenbery; R S Shapiro; D J Weisdorf; L L Robison; J S Miller; J P Neglia Journal: Blood Date: 1996-05-01 Impact factor: 22.113
Authors: Yutaka Yasui; Yan Liu; Joseph P Neglia; Debra L Friedman; Smita Bhatia; Anna T Meadows; Lisa R Diller; Ann C Mertens; John Whitton; Leslie L Robison Journal: Am J Epidemiol Date: 2003-12-01 Impact factor: 5.363
Authors: Lucie M Turcotte; Joseph P Neglia; Raoul C Reulen; Cecile M Ronckers; Flora E van Leeuwen; Lindsay M Morton; David C Hodgson; Yutaka Yasui; Kevin C Oeffinger; Tara O Henderson Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Peter D Inskip; Alice J Sigurdson; Lene Veiga; Parveen Bhatti; Cécile Ronckers; Preetha Rajaraman; Houda Boukheris; Marilyn Stovall; Susan Smith; Sue Hammond; Tara O Henderson; Tanya C Watt; Ann C Mertens; Wendy Leisenring; Kayla Stratton; John Whitton; Sarah S Donaldson; Gregory T Armstrong; Leslie L Robison; Joseph P Neglia Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-15 Impact factor: 7.038
Authors: Kristy R Kutanzi; Annie Lumen; Igor Koturbash; Isabelle R Miousse Journal: Int J Environ Res Public Health Date: 2016-10-28 Impact factor: 3.390